卵清蛋白
免疫系统
抗原
化学
免疫
微生物学
生发中心
微熔池
肠沙门氏菌
跨细胞
树突状细胞
派尔斑
抗体
接种疫苗
先天免疫系统
免疫学
介孔二氧化硅
获得性免疫系统
免疫
生物
多糖
肠粘膜
作者
Lin Yu,Xiaofeng Shi,Yaming Yu,Gaofeng Cai,Xuping Zhao,Fangzhu Lin,Xuanqi Lu,Jie Qiao,Yushan Fang,Kexin Fang,Yanrong Yang,Deyun Wang
标识
DOI:10.1016/j.mtbio.2026.103391
摘要
Intestinal vaccination faces several key challenges, including limited epithelial interaction, inefficient antigen uptake, and insufficient immune stimulation. Here, we developed a virus-inspired oral nanovaccine based on spiky mesoporous silica nanoparticles (VMSNs) functionalized with Rehmannia glutinosa polysaccharide (RGP), a natural polysaccharide with favorable intestinal biocompatibility. The resulting RGP-VMSN showed enhanced intestinal retention and epithelial interaction and was associated with increased antigen accessibility within the mucosal environment, reflected by stronger antigen-associated signals at mucosal immune sites. Using ovalbumin (OVA) as a model antigen, oral OVA@RGP-VMSN vaccination was associated with increased intestinal dendritic cell activation, enhanced germinal center responses, and elevated antigen-specific antibody production, together with coordinated mucosal and systemic immune responses. Furthermore, immunization with a Salmonella enterica serovar Typhimurium lysate-loaded nanovaccine improved protection in a murine challenge model. Overall, this strategy represents a promising platform for oral and mucosal nanovaccine development.
科研通智能强力驱动
Strongly Powered by AbleSci AI